These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2668 related items for PubMed ID: 18477802

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Choosing the best endpoint.
    Christensen E.
    J Hepatol; 2008 Oct; 49(4):672-3. PubMed ID: 18718690
    [Abstract] [Full Text] [Related]

  • 3. Re: Design and endpoints of clinical trials in hepatocellular carcinoma.
    Di Maio M, Daniele B, Gallo C, Perrone F.
    J Natl Cancer Inst; 2008 Nov 05; 100(21):1557; author reply 1557-8. PubMed ID: 18957679
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
    Lencioni R, Chen XP, Dagher L, Venook AP.
    Oncologist; 2010 Nov 05; 15 Suppl 4():42-52. PubMed ID: 21115580
    [Abstract] [Full Text] [Related]

  • 5. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
    Rimassa L, Santoro A.
    Expert Rev Anticancer Ther; 2009 Jun 05; 9(6):739-45. PubMed ID: 19496710
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
    Lencioni R, Llovet JM.
    Semin Liver Dis; 2010 Feb 05; 30(1):52-60. PubMed ID: 20175033
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma.
    Peck-Radosavljevic M, Greten TF, Lammer J, Rosmorduc O, Sangro B, Santoro A, Bolondi L.
    Eur J Gastroenterol Hepatol; 2010 Apr 05; 22(4):391-8. PubMed ID: 19940784
    [Abstract] [Full Text] [Related]

  • 14. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY.
    Oncology; 2011 Apr 05; 81 Suppl 1():141-7. PubMed ID: 22212948
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
    Wörns MA, Weinmann A, Pfingst K, Schulte-Sasse C, Messow CM, Schulze-Bergkamen H, Teufel A, Schuchmann M, Kanzler S, Düber C, Otto G, Galle PR.
    J Clin Gastroenterol; 2009 Apr 05; 43(5):489-95. PubMed ID: 19247201
    [Abstract] [Full Text] [Related]

  • 16. [Methodological approaches of clinical studies with targeted therapies].
    Penel N, Saleron J, Lansiaux A, Clisant S, Adenis A, Fournier C, Duhamel A, Bonneterre J.
    Bull Cancer; 2008 Feb 05; 95(2):185-90. PubMed ID: 18304903
    [Abstract] [Full Text] [Related]

  • 17. Systemic therapy for advanced hepatocellular carcinoma: a review.
    Nowak AK, Chow PK, Findlay M.
    Eur J Cancer; 2004 Jul 05; 40(10):1474-84. PubMed ID: 15196530
    [Abstract] [Full Text] [Related]

  • 18. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.
    Llovet JM, Fuster J, Bruix J, Barcelona-Clínic Liver Cancer Group.
    Liver Transpl; 2004 Feb 05; 10(2 Suppl 1):S115-20. PubMed ID: 14762851
    [Abstract] [Full Text] [Related]

  • 19. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH, Kudo M, Ye SL, Choi JY, Poon RT, Seong J, Park JW, Ichida T, Chung JW, Chow P, Cheng AL.
    Oncology; 2011 Feb 05; 81 Suppl 1():158-64. PubMed ID: 22212951
    [Abstract] [Full Text] [Related]

  • 20. Current strategy for staging and treatment: the BCLC update and future prospects.
    Forner A, Reig ME, de Lope CR, Bruix J.
    Semin Liver Dis; 2010 Feb 05; 30(1):61-74. PubMed ID: 20175034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 134.